A lawsuit filed last week accuses Johnson & Johnson of conspiring with pharmaceutical consultant Omnicare in an effort to push J&J drugs on nursing home residents, and violating federal Medicaid laws in the process.
As a result of the scheme, "residents were overcharged for their medications, had additional medications administered and were unlawfully switched to Johnson & Johnson drugs," all in the name of increasing revenue, according to the lawsuit.
According to the suit, the companies also came up with a way to get around Medicaid's "best price law," a federal statute intended to ensure that Medicaid pays as little as possible for prescription drugs. Under the law, once the discounts and rebates exceeded a certain level, the companies would have been required to pass them along to Medicaid.
A new COVID variant known as NB.1.8.1 has made landfall in the United States. The variant,...
To accomplish its mission of increasing the health security of the U.S., the Centers for Disease...
